niraparib tosilate monohydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ZEJULA niraparib (as tosilate monohydrate) 100 mg capsule blister pack
AUST R: 305254
Active ingredients:
niraparib tosilate monohydrate

Dosage form:
Capsule, hard

Sponsor:
GlaxoSmithKline Australia Pty Ltd

Phone:
1800033109

Deletion from market:
31 Jan 2025

Shortage status:
To be discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Other generic by same sponsor is available. ZEJULA niraparib (as tosilate monohydrate) 100 mg film-coated tablet blister pack ARTG 395406